News Conference News EuroPCR 2016 ‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR Yael L. Maxwell May 18, 2016
News Daily News Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits Todd Neale May 16, 2016
News Daily News Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests Todd Neale May 12, 2016
News Daily News When Problems Arise With Prosthetic Heart Valves, Multimodality Imaging Is Needed, Say European Guidelines Todd Neale May 06, 2016
News Daily News ¿Predilatación o No Predilatación en TAVR? Una Serie Europea Tranquiliza en Ambos Sentidos Michael O'Riordan May 02, 2016
News Daily News Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways Michael O'Riordan May 02, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News Un Estudio Avala que es Seguro Proceder a la UCI Post-TAVR en Pacientes Seleccionados Todd Neale April 27, 2016
News Daily News Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients Todd Neale April 27, 2016
News Opinion Editor's Corner ACC 2016 Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016 Shelley Wood April 13, 2016
News Conference News ACC 2016 CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results Shelley Wood April 08, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
Presentation Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR Presenter: G. Michael Deeb April 06, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough? Shelley Wood April 03, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016
News Conference News ACC 2016 When Chosen Wisely, 90-Year-Olds Do Well After TAVR Caitlin E. Cox April 02, 2016
News Conference News ACC 2016 TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral Shelley Wood April 02, 2016